History

registration granted by the American FDA for the manufacture of antibiotics
the Dawa Pharmaceutical production plants began operation in Kenya
fermentation capacities were increased by 50 %
construction of a plant for converting pharmaceutical active ingredients into finished products
investment in preservation of clean waters and environment protection
construction of the factory in Ljutomer
investment in tourist/health-resort facilities

construction of a plant producing insulation material
building marketing network abroad (establishment of companies and representative offices)
accelerated development of Krka’s own generic drugs, and continual cooperation with the leading international pharmaceutical companies
ranking in the top Slovene companies and exporters
modernisation of fermentation production
ensuring a highly qualified professional work force through the project of staff development
increased investment in research and development

top-place ranking among pharmaceutical companies in Central and Eastern Europe, and penetration into Western European markets
investment in research and development activities
upgrading the Total Quality Management system
restructuring into a joint-stock company

completion of the construction of the modern plant Notol for the production of solid dosage at the central Krka location
expansion of production-distribution network abroad (new production-distribution plants in Poland, the Russian Federation and in Croatia)
a new plant for the production of solid dosage forms in Šentjernej
expansion of marketing and sales network
Development and Control Centre 2
Acquisition of ISO 14001 standard (new quality in environment protection)
Implementation of the new SAP information system
Acquisition of the foodstuff safety system certificate (HACCP), safety and health at work (OHSAS 18001) and the certificate by the European Agency for Safety and Health at Work (EU-OSHA)
Construction of the plant for the production of active pharmaceutical ingredients Synthesis 4

Expansion of the marketing and sales network
Opening of Sinteza 4 API plant
Introduction of no-par value shares (1:10 share split)
Acquisition of ISO/IEC 27001 certificate for the information security system
Highest national award for quality – the Business Excellence Award of the Republic of Slovenia (PRSPO) for 2007.
Opening of the new injection production plant
A new business centre for warehousing products, customs operations and marketing activities in Macedonia
Entry into a private Chinese pharmaceutical and chemical companies Zhejiang Menova Pharmaceuticals Co., Ltd., Shanghai and Anhua Menova Pharmaceuticals Co., Ltd., Gvande
Purchase of German company TAD Pharma GmbH from Cuxhavna and Austrian company Alternova Arzneimittell GmbH from Vienna
New chemical development laboratories

Opening of a state-of-the-art syrup production plant
Opening of a state-of-the-art plant for the production of products with biocidal effect
Starting the solar power plant
Renovation and enlargement of a high bay warehouse for packaging material
Opening of a state-of-the-art solid dosage forms production plant
Opening of development and control centre RKC 3
Listing of Krka's shares on the Warsaw Stock Exchange
Founding the company Farma GRS, d. o. o., together with partners within the pharmaceutical industry development project and building development and research, and production capacities
Opening of the Krka-Rus 2 plant in the Russian Federation
Opening of the plant for the production of active pharmaceutical ingredients Sinteza 1 in Krško
Opening of the largest investment in Krka's history – a plant for the production of solid dosage forms Notol 2 with an annual production capacity of 4.5 billion of finished products
Opening of a plant for the new generation lozenges in Ljutomer
Strengthening the marketing and sales network comprising 28 subsidiaries and 19 representative offices together with production and distribution companies